|
1
|
Freeman RV and Otto CM: Spectrum of
calcific aortic valve disease: Pathogenesis, disease progression,
and treatment strategies. Circulation. 111:3316–3326. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iung B, Baron G, Butchart EG, Delahaye F,
Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer
F, Boersma E, et al: A prospective survey of patients with valvular
heart disease in Europe: The Euro heart survey on valvular heart
disease. Eur Heart J. 24:1231–1243. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rajamannan NM, Evans FJ, Aikawa E,
Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS,
Mathieu P, O'Brien KD, et al: Calcific aortic valve disease: Not
simply a degenerative process: A review and agenda for research
from the National heart and lung and blood institute aortic
stenosis working group. Executive summary: Calcific aortic valve
disease-2011 update. Circulation. 124:1783–1791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jian B, Narula N, Li QY, Mohler ER III and
Levy RJ: Progression of aortic valve stenosis: TGF-beta1 is present
in calcified aortic valve cusps and promotes aortic valve
interstitial cell calcification via apoptosis. Ann Thorac Surg.
75:457–466. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galeone A, Brunetti G, Oranger A, Greco G,
Di Benedetto A, Mori G, Colucci S, Zallone A, Paparella D and Grano
M: Aortic valvular interstitial cells apoptosis and calcification
are mediated by TNF-related apoptosis-inducing ligand. Int J
Cardiol. 169:296–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cotè N, Mahmut A, Bosse Y, Couture C, Pagé
S, Trahan S, Boulanger MC, Fournier D, Pibarot P and Mathieu P:
Inflammation is associated with the remodeling of calcific aortic
valve disease. Inflammation. 36:573–581. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Brien KD: Epidemiology and genetics of
calcific aortic valve disease. J Investig Med. 55:284–291. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andersson U, Erlandsson-Harris H, Yang H
and Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol.
72:1084–1091. 2002.PubMed/NCBI
|
|
9
|
Ueda T, Chou H, Kawase T, Shirakawa H and
Yoshida M: Acidic C-tail of HMGB1 is required for its target
binding to nucleosome linker DNA and transcription stimulation.
Biochemistry. 43:9901–9908. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamada S and Maruyama I: HMGB1, a novel
inflammatory cytokine. Clin Chim Acta. 375:36–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Ling Y, Huang M, Yin T, Gou SM, Zhan
NY, Xiong JX, Wu HS, Yang ZY and Wang CY: Heparin inhibits the
inflammatory response induced by LPS and HMGB1 by blocking the
binding of HMGB1 to the surface of macrophages. Cytokine. 72:36–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nativel B, Marimoutou M, Thon-Hon VG,
Gunasekaran MK, Andries J, Stanislas G, Planesse C, Da Silva CR,
Césari M, Iwema T, et al: Soluble HMGB1 is a novel adipokine
stimulating IL-6 secretion through RAGE receptor in SW872
preadipocyte cell line: Contribution to chronic inflammation in fat
tissue. PLoS One. 8:e760392013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou C, Kong J, Liang Y, Huang H, Wen H,
Zheng X, Wu L and Chen Y: HMGB1 contributes to allergen-induced
airway remodeling in a murine model of chronic asthma by modulating
airway inflammation and activating lung fibroblasts. Cell Mol
Immunol. 12:409–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Min HJ, Kim SJ, Kim TH, Chung HJ, Yoon JH
and Kim CH: Level of secreted HMGB1 correlates with severity of
inflammation in chronic rhinosinusitis. Laryngoscope.
125:E225–E330. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lotze MT and Tracey KJ: High-mobility
group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal.
Nat Rev Immunol. 5:331–342. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng XS, Meng X, Zeng Q, Fullerton D,
Mitchell M and Jaggers J: Adult aortic valve interstitial cells
have greater responses to toll-like receptor 4 stimulation. Ann
Thorac Surg. 99:62–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng X, Ao L, Song Y, Babu A, Yang X, Wang
M, Weyant MJ, Dinarello CA, Cleveland JC Jr and Fullerton DA:
Expression of functional Toll-like receptors 2 and 4 in human
aortic valve interstitial cells: Potential roles in aortic valve
inflammation and stenosis. Am J Physiol Cell Physiol. 294:C29–C35.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng Q, Song R, Ao L, Weyant MJ, Lee J, Xu
D, Fullerton DA and Meng X: Notch1 promotes the pro-osteogenic
response of human aortic valve interstitial cells via modulation of
ERK1/2 and nuclear factor-κB activation. Arterioscler Thromb Vasc
Biol. 33:1580–1590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mathieu P, Boulanger MC and Bouchareb R:
Molecular biology of calcific aortic valve disease: Towards new
pharmacological therapies. Expert Rev Cardiovasc Ther. 12:851–862.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mohler ER III, Chawla MK, Chang AW,
Vyavahare N, Levy RJ, Graham L and Gannon FH: Identification and
characterization of calcifying valve cells from human and canine
aortic valves. J Heart Valve Dis. 8:254–260. 1999.PubMed/NCBI
|
|
21
|
Mathieu P, Voisine P, Pépin A, Shetty R,
Savard N and Dagenais F: Calcification of human valve interstitial
cells is dependent on alkaline phosphatase activity. J Heart Valve
Dis. 14:353–357. 2005.PubMed/NCBI
|
|
22
|
Osman L, Yacoub MH, Latif N, Amrani M and
Chester AH: Role of human valve interstitial cells in valve
calcification and their response to atorvastatin. Circulation.
114:(1 Suppl). I547–I552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Towler DA: Molecular and cellular aspects
of calcific aortic valve disease. Circ Res. 113:198–208. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji Y, Liu J, Wang Z and Liu N: Angiotensin
II induces inflammatory response partly via toll-like receptor
4-dependent signaling pathway in vascular smooth muscle cells. Cell
Physiol Biochem. 23:265–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pasipoularides A: Calcific Aortic valve
disease: Part 1-molecular pathogenetic aspects, hemodynamics, and
adaptive feedbacks. J Cardiovasc Transl Res. 9:102–118. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Shan J, Yang W, Zheng H and Xue S:
High mobility group box 1 (HMGB1) mediates high-glucose-induced
calcification in vascular smooth muscle cells of saphenous veins.
Inflammation. 36:1592–1604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai CH, Shi GY, Lee FT, Kuo CH, Cheng TL,
Chang BI, Ma CY, Hsu FC, Yang YJ and Wu HL: Recombinant human
thrombomodulin suppresses experimental abdominal aortic aneurysms
induced by calcium chloride in mice. Ann Surg. 258:1103–1110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Steitz SA, Speer MY, Curinga G, Yang HY,
Haynes P, Aebersold R, Schinke T, Karsenty G and Giachelli CM:
Smooth muscle cell phenotypic transition associated with
calcification: Upregulation of Cbfa1 and downregulation of smooth
muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tyson KL, Reynolds JL, McNair R, Zhang Q,
Weissberg PL and Shanahan CM: Osteo/chondrocytic transcription
factors and their target genes exhibit distinct patterns of
expression in human arterial calcification. Arterioscler Thromb
Vasc Biol. 23:489–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Byon CH, Javed A, Dai Q, Kappes JC,
Clemens TL, Darley-Usmar VM, McDonald JM and Chen Y: Oxidative
stress induces vascular calcification through modulation of the
osteogenic transcription factor Runx2 by AKT signaling. J Biol
Chem. 283:15319–15327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai CF, Shao JS, Behrmann A, Krchma K,
Cheng SL and Towler DA: TNFR1-activated reactive oxidative species
signals up-regulate osteogenic Msx2 programs in aortic
myofibroblasts. Endocrinology. 153:3897–3910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steitz SA, Speer MY, McKee MD, Liaw L,
Almeida M, Yang H and Giachelli CM: Osteopontin inhibits mineral
deposition and promotes regression of ectopic calcification. Am J
Pathol. 161:2035–2046. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sowa AK, Kaiser FJ, Eckhold J, Kessler T,
Aherrahrou R, Wrobel S, Kaczmarek PM, Doehring L, Schunkert H,
Erdmann J and Aherrahrou Z: Functional interaction of osteogenic
transcription factors Runx2 and Vdr in transcriptional regulation
of Opn during soft tissue calcification. Am J Pathol. 183:60–68.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zeng Q, Song R, Ao L, Xu D, Venardos N,
Fullerton DA and Meng X: Augmented osteogenic responses in human
aortic valve cells exposed to oxLDL and TLR4 agonist: A mechanistic
role of Notch1 and NF-κB interaction. PLoS One. 9:e954002014.
View Article : Google Scholar : PubMed/NCBI
|
